ZYVERSA THERAPEUTICS, INC.Side Letter to Business Combination Agreement • November 3rd, 2022 • Larkspur Health Acquisition Corp. • Pharmaceutical preparations • New York
Reference is made to the Business Combination Agreement, dated as of July 20, 2022 (the “Agreement”) by and among Larkspur Health Acquisition Corp. (the “SPAC”), Larkspur Merger Sub, Inc. (“Merger Sub”), ZyVersa Therapeutics, Inc. (the “Company”) and the representative of the shareholders of the Company named therein (the “Securityholder Representative”). Capitalized terms used herein and not defined shall have the respective meanings ascribed to such terms under the Agreement.
Redwoods Acquisition Corp.Side Letter to Business Combination Agreement • April 17th, 2024 • Redwoods Acquisition Corp. • Biological products, (no disgnostic substances)
Reference is made to that certain Business Combination Agreement, dated May 30, 2023 (as amended by the first amendment thereto, the “Merger Agreement”), by and among Redwoods Acquisition Corp., a Delaware corporation (the “Company”), Anew Medical Sub, Inc., a Wyoming corporation and direct, wholly owned subsidiary of Redwoods (“Merger Sub”), and Anew Medical, Inc., a Wyoming corporation (“ANEW”). Capitalized terms used and not defined herein shall have the respective meanings ascribed to them in the Merger Agreement.
